These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


151 related items for PubMed ID: 173490

  • 1. Effects of repeated doses of scopolamine on the electroencephalographic stages of sleep in normal volunteers.
    Sagalés T, Erill S, Domino EF.
    Clin Pharmacol Ther; 1975 Dec; 18(6):727-32. PubMed ID: 173490
    [Abstract] [Full Text] [Related]

  • 2. Age-related effects of scopolamine on REM sleep regulation in normal control subjects: relationship to sleep abnormalities in depression.
    Rao U, Lutchmansingh P, Poland RE.
    Neuropsychopharmacology; 1999 Dec; 21(6):723-30. PubMed ID: 10633478
    [Abstract] [Full Text] [Related]

  • 3. The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group.
    Gillin JC, Sutton L, Ruiz C, Darko D, Golshan S, Risch SC, Janowsky D.
    Biol Psychiatry; 1991 Jul 15; 30(2):157-69. PubMed ID: 1655072
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of scopolamine on nocturnal cortisol secretion, sleep architecture, and REM latency in normal volunteers: relation to sleep and cortisol abnormalities in depression.
    Poland RE, Tondo L, Rubin RT, Trelease RB, Lesser IM.
    Biol Psychiatry; 1989 Feb 15; 25(4):403-12. PubMed ID: 2930809
    [Abstract] [Full Text] [Related]

  • 5. Induction and resetting of REM sleep rhythm in normal man by arecholine: blockade by scopolamine.
    Sitaram N, Moore AM, Gillin JC.
    Sleep; 1978 Sep 15; 1(1):83-90. PubMed ID: 227024
    [Abstract] [Full Text] [Related]

  • 6. Transdermal scopolamine alters phasic REM activity in normal young adults.
    Kim EJ, Jeong DU.
    Sleep; 1999 Jun 15; 22(4):515-20. PubMed ID: 10389227
    [Abstract] [Full Text] [Related]

  • 7. REM sleep and cortisol responses to scopolamine during depression and remission in women.
    Rao U, Lin KM, Schramm P, Poland RE.
    Int J Neuropsychopharmacol; 2004 Sep 15; 7(3):265-74. PubMed ID: 15132761
    [Abstract] [Full Text] [Related]

  • 8. Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man.
    Feinberg I, Jones R, Walker JM, Cavness C, March J.
    Clin Pharmacol Ther; 1975 Apr 15; 17(4):458-66. PubMed ID: 164314
    [Abstract] [Full Text] [Related]

  • 9. Development of tolerance after repeated administration of a selective muscarinic M1 antagonist biperiden in healthy human volunteers.
    Salin-Pascual RJ, Granados-Fuentes D, Galicia-Polo L, Nieves E, Gillin JC.
    Biol Psychiatry; 1993 Feb 01; 33(3):188-93. PubMed ID: 8448266
    [Abstract] [Full Text] [Related]

  • 10. Sleep electroencephalographic abnormalities in adolescent depressives: effects of scopolamine.
    McCracken JT, Poland RE, Lutchmansingh P, Edwards C.
    Biol Psychiatry; 1997 Oct 01; 42(7):577-84. PubMed ID: 9376454
    [Abstract] [Full Text] [Related]

  • 11. Scopolamine-induced muscarinic supersensitivity in normal man: changes in sleep.
    Sitaram N, Moore AM, Gillin JC.
    Psychiatry Res; 1979 Jul 01; 1(1):9-16. PubMed ID: 233155
    [Abstract] [Full Text] [Related]

  • 12. Suppression of eltoprazine-induced REM sleep rebound by scopolamine.
    Stickgold R, Williams J, Datta S, Quattrochi J, Hobson JA.
    Neuropharmacology; 1993 May 01; 32(5):447-53. PubMed ID: 8321426
    [Abstract] [Full Text] [Related]

  • 13. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
    Barbanoj MJ, Clos S, Romero S, Morte A, Giménez S, Lorenzo JL, Luque A, Dal-Ré R.
    Neuropsychobiology; 2005 May 01; 51(3):134-47. PubMed ID: 15838185
    [Abstract] [Full Text] [Related]

  • 14. REM sleep in depression is influenced by ethnicity.
    Poland RE, Rao U, Lutchmansingh P, McCracken JT, Lesser IM, Edwards C, Ott GE, Lin KM.
    Psychiatry Res; 1999 Nov 08; 88(2):95-105. PubMed ID: 10622346
    [Abstract] [Full Text] [Related]

  • 15. Effects of central dopaminergic blockade with primozide upon the EEG stages of sleep in man.
    Sagalés T, Erill S.
    Psychopharmacologia; 1975 Nov 08; 41(1):53-6. PubMed ID: 164679
    [Abstract] [Full Text] [Related]

  • 16. Biperiden administration during REM sleep deprivation diminished the frequency of REM sleep attempts.
    Salin-Pascual RJ, Grandos-Fuentes D, Galicia-Polo L, Nieves E, Roehrs TA, Roth T.
    Sleep; 1992 Jun 08; 15(3):252-6. PubMed ID: 1621026
    [Abstract] [Full Text] [Related]

  • 17. Effects of moclobemide on sleep in healthy human subjects.
    Blois R, Gaillard JM.
    Acta Psychiatr Scand Suppl; 1990 Jun 08; 360():73-5. PubMed ID: 2248081
    [Abstract] [Full Text] [Related]

  • 18. Dynamic suppression of REM sleep by parenteral administration of the serotonin-1 agonist eltoprazine.
    Quattrochi JJ, Mamelak A, Binder DK, Williams J, Rittenhouse C, Hobson JA.
    Sleep; 1992 Apr 08; 15(2):125-32. PubMed ID: 1579786
    [Abstract] [Full Text] [Related]

  • 19. Insomnia in the elderly: treatment with flurazepam hydrochloride.
    Frost JD, DeLucchi MR.
    J Am Geriatr Soc; 1979 Dec 08; 27(12):541-6. PubMed ID: 229146
    [Abstract] [Full Text] [Related]

  • 20. The cholinergic REM induction test with RS 86 after scopolamine pretreatment in healthy subjects.
    Riemann D, Hohagen F, Fleckenstein P, Schredl M, Berger M.
    Psychiatry Res; 1991 Sep 08; 38(3):247-60. PubMed ID: 1754637
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.